Literature DB >> 2902123

Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses.

B J Furr1, J R Woodburn.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 2902123     DOI: 10.1007/BF03350179

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  215 in total

1.  Relation between growth of carcinogen-induced mammary cancers and serum prolactin values in rats.

Authors:  H Nagasawa; C L Chen; J Meites
Journal:  Proc Soc Exp Biol Med       Date:  1973-02

Review 2.  Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.

Authors:  S S Yen
Journal:  Fertil Steril       Date:  1983-03       Impact factor: 7.329

3.  Effect of an LHRH agonist on pituitary and testicular function in rhesus monkeys.

Authors:  K Sundaram; R B Thau; M Goldstein; D M Phillips; J Rivier; W Vale; C W Bardin
Journal:  J Reprod Fertil       Date:  1984-11

4.  Pulsatile low dose luteinizing hormone-releasing hormone treatment for induction of follicular maturation and ovulation in women with amenorrhoea.

Authors:  G Skarin; S J Nillius; L Wide
Journal:  Acta Endocrinol (Copenh)       Date:  1982-09

5.  Gonadotropin-releasing hormone analogue binds to luteal cells and inhibits progesterone production.

Authors:  R N Clayton; J P Harwood; K J Catt
Journal:  Nature       Date:  1979-11-01       Impact factor: 49.962

6.  Postcoital contraceptive effects of agonist analogs of luteinizing hormone-releasing hormone.

Authors:  A Corbin; C W Beattie; R Rees; J Yardley; T J Foell; S Y Chai; H McGregor; V Garsky; D Sarantakis; W A McKinley
Journal:  Fertil Steril       Date:  1977-04       Impact factor: 7.329

7.  The presence of LHRH-like receptors in Dunning R3327H prostate tumors.

Authors:  M T Hierowski; P Altamirano; T W Redding; A V Schally
Journal:  FEBS Lett       Date:  1983-04-05       Impact factor: 4.124

8.  Induction of ovulation and pregnancy with pulsatile luteinizing hormone releasing factor: dosage and mode of delivery.

Authors:  R L Reid; G R Leopold; S S Yen
Journal:  Fertil Steril       Date:  1981-11       Impact factor: 7.329

9.  Effect of oestrogen on gonadotrophin release in stumptailed monkeys (Macaca arctoides) treated chronically with an agonist analogue of luteinizing hormone releasing hormone.

Authors:  H M Fraser
Journal:  J Endocrinol       Date:  1981-12       Impact factor: 4.286

10.  Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty.

Authors:  W F Crowley; F Comite; W Vale; J Rivier; D L Loriaux; G B Cutler
Journal:  J Clin Endocrinol Metab       Date:  1981-02       Impact factor: 5.958

View more
  6 in total

Review 1.  Transport of peptide and protein drugs across biological membranes.

Authors:  J C Verhoef; H E Boddé; A G de Boer; J A Bouwstra; H E Junginger; F W Merkus; D D Breimer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

2.  Use of clomifene during early pregnancy and risk of hypospadias: population based case-control study.

Authors:  Henrik Toft Sørensen; Lars Pedersen; Mette Vinther Skriver; Mette Nørgaard; Bente Nørgård; Elizabeth E Hatch
Journal:  BMJ       Date:  2004-12-21

3.  Effect of pulsatile luteinizing hormone-releasing hormone administration on pituitary-gonadal function in elderly man.

Authors:  M Giusti; G Marini; L Traverso; P Cavagnaro; L Granziera; G Giordano
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

Review 4.  Adverse bone effects of medications used to treat non-skeletal disorders.

Authors:  N B Watts
Journal:  Osteoporos Int       Date:  2017-07-27       Impact factor: 4.507

5.  Stability of gonadorelin and triptorelin in aqueous solution.

Authors:  V J Helm; B W Müller
Journal:  Pharm Res       Date:  1990-12       Impact factor: 4.200

6.  Hormonal treatment of pancreatic carcinoma: a phase II study of LHRH agonist goserelin plus hydrocortisone.

Authors:  P A Philip; J Carmichael; K Tonkin; P K Buamah; J Britton; M Dowsett; A L Harris
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.